The long-term goal of this project is the development of an adequate database concerning the antigenic, protein, lipopolysaccharide and molecular composition of ehrlichiae of medical importance. Such information would form the foundation for studies of the unusual host immune reactions stimulated by these agents, the function of ehrlichial proteins in intracellular life and the contributions of such proteins toward host cell injury. The increasing numbers of human patients with severe morbidity or fatal outcome when infected with ehrlichiae attests to the need for such studies. With the recent development of an efficient method for propagation of E. canis, the previous obstacles to in-depth modern investigation have been removed. The proposal developed herein allows for development of specific polyclonal and monoclonal antibodies to identify antigens specific for or shared among ehrlichiae, and the determination of protein and lipopolysaccharide composition of these molecules. Such basic studies will establish a framework for investigating host immune responses toward B-cell epitopes on these antigens. The ultrastructural localization of antigens by specific antibodies will identify bacterial surface components in a location most likely to interact with host cell components. While B-cell reactive antigens may be used as markers in various experiments, T-cell epitopes are more likely to be important in immune reactions against intracellular bacteria such as E. canis. The evaluation of canine T-cell responses elicited by acute E. canis infection and by specific surface-exposed major immunodominant protein antigens may provide an approach toward understanding the abnormal cellular immune responses and lack of persistent immunity to ehrlichiae. To understand the molecular biology of these antigens, one or more which are major surfaced-exposed proteins and contain T-cell epitopes will be identified in a genomic library of E. canis, and the recombinant DNA will be sequenced. Fundamental studies such as these will provide the tools and practical basis necessary to dissect immune responses to component antigens, to study the function of proteins in the intracellular life of the ehrlichia, and to investigate the pathogenic mechanisms which involve these proteins and cause host cell injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI031431-02
Application #
3146446
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1991-09-30
Project End
1995-07-31
Budget Start
1992-09-01
Budget End
1993-07-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Cheng, Yan; Liu, Yan; Wu, Bin et al. (2014) Proteomic analysis of the Ehrlichia chaffeensis phagosome in cultured DH82 cells. PLoS One 9:e88461
Thirumalapura, Nagaraja R; Crocquet-Valdes, Patricia A; Saito, Tais B et al. (2013) Recombinant Ehrlichia P29 protein induces a protective immune response in a mouse model of ehrlichiosis. Vaccine 31:5960-7
Ismail, Nahed; Walker, David H; Ghose, Purnima et al. (2012) Immune mediators of protective and pathogenic immune responses in patients with mild and fatal human monocytotropic ehrlichiosis. BMC Immunol 13:26
Crocquet-Valdes, Patricia A; Thirumalapura, Nagaraja R; Ismail, Nahed et al. (2011) Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis. Clin Vaccine Immunol 18:2018-25
Thomas, Sunil; Thirumalapura, Nagaraja R; Crocquet-Valdes, Patricia A et al. (2011) Structure-based vaccines provide protection in a mouse model of ehrlichiosis. PLoS One 6:e27981
Liu, Yan; Zhang, Zhikai; Jiang, Yongquan et al. (2011) Obligate intracellular bacterium Ehrlichia inhibiting mitochondrial activity. Microbes Infect 13:232-8
McBride, Jere W; Walker, David H (2011) Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies. Expert Rev Mol Med 13:e3
Stevenson, Heather L; Estes, Mark D; Thirumalapura, Nagaraja R et al. (2010) Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome. Am J Pathol 177:766-76
McBride, Jere W; Walker, David H (2010) Progress and obstacles in vaccine development for the ehrlichioses. Expert Rev Vaccines 9:1071-82
Thomas, Sunil; Popov, Vsevolod L; Walker, David H (2010) Exit mechanisms of the intracellular bacterium Ehrlichia. PLoS One 5:e15775

Showing the most recent 10 out of 18 publications